The impact of site and extent of clinically evident cardiovascular disease and atherosclerotic burden on new cardiovascular events in patients with Type 2 diabetes. The SMART study

Diabetic Medicine

Volumn 24, Issue 12, 2007, Pages 1352-1360

  Gorter, P M ^a   Visseren, F L J ^a   Algra, A ^a,b   Van Der Graaf, Y ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Atherosclerotic burden; Cardiovascular risk; Extent of clinically evident cardiovascular disease; Site of clinically evident cardiovascular disease; Type 2 diabetes

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ALBUMINURIA; ARTERY DISEASE; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; QUANTITATIVE ANALYSIS; RISK ASSESSMENT;

ADULT; AGED; ALBUMINURIA; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CAROTID ARTERY, COMMON; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS;

EID: 36549009964     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2007.02323.x     Document Type: Article

References (28)

1. Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 1979 2 : 120 126.
2. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993 16 : 434 444.
3. Vinik A, Flemmer M. Diabetes and macrovascular disease. J Diabetes Complications 2002 16 : 235 245.
4. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998 339 : 229 234.
5. Lotufo PA, Gaziano JM, Chae CU, Ajani UA, Moreno-John G, Buring JE et al. Diabetes and all-cause and coronary heart disease mortality among US male physicians. Arch Intern Med 2001 161 : 242 247.
6. Evans JM, Wang J, Morris AD. Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies. BMJ 2002 324 : 939 942.
7. Cho E, Rimm EB, Stampfer MJ, Willett WC, Hu FB. The impact of diabetes mellitus and prior myocardial infarction on mortality from all causes and from coronary heart disease in men. J Am Coll Cardiol 2002 40 : 954 960.
8. Eberly LE, Cohen JD, Prineas R, Yang L. Impact of incident diabetes and incident nonfatal cardiovascular disease on 18-year mortality: the multiple risk factor intervention trial experience. Diabetes Care 2003 26 : 848 854.
9. Becker A, Bos G, de Vegt F, Kostense PJ, Dekker JM, Nijpels G et al. Cardiovascular events in type 2 diabetes: comparison with nondiabetic individuals without and with prior cardiovascular disease. 10-year follow-up of the Hoorn Study. Eur Heart J 2003 24 : 1406 1413.
10. Juutilainen A, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Type 2 diabetes as a 'coronary heart disease equivalent': an 18-year prospective population-based study in Finnish subjects. Diabetes Care 2005 28 : 2901 2907.
11. Howard BV, Best LG, Galloway JM, Howard WJ, Jones K, Lee ET et al. Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors. Diabetes Care 2006 29 : 391 397.
12. Hu FB, Stampfer MJ, Solomon CG, Liu S, Willett WC, Speizer FE et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med 2001 161 : 1717 1723.
13. Ho JE, Paultre F, Mosca L. Is diabetes mellitus a cardiovascular disease risk equivalent for fatal stroke in women? Data from the Women's Pooling Project. Stroke 2003 34 : 2812 2816.
14. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr., Clark LT, Hunninghake DB et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004 110 : 227 239.
15. Lee CD, Folsom AR, Pankow JS, Brancati FL. Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction. Circulation 2004 109 : 855 860.
16. Steg PG, Bhatt DL, Wilson PW, D'Agostino R Sr, Ohman EM, Rother J et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 2007 297 : 1197 1206.
17. Asakawa H, Tokunaga K, Kawakami F. Comparison of risk factors of macrovascular complications. Peripheral vascular disease, cerebral vascular disease, and coronary heart disease in Japanese type 2 diabetes mellitus patients. J Diabetes Complications 2000 14 : 307 313.
18. Yamasaki Y, Kodama M, Nishizawa H, Sakamoto K, Matsuhisa M, Kajimoto Y et al. Carotid intima-media thickness in Japanese type 2 diabetic subjects: predictors of progression and relationship with incident coronary heart disease. Diabetes Care 2000 23 : 1310 1315.
19. Simons PC, Algra A, van de Laak MF, Grobbee DE, van der Graaf Y. Second manifestations of ARTerial disease (SMART) study: rationale and design. Eur J Epidemiol 1999 15 : 773 781.
20. Bots ML, Hofman A, De Jong PT, Grobbee DE. Common carotid intima-media thickness as an indicator of atherosclerosis at other sites of the carotid artery. The Rotterdam Study. Ann Epidemiol 1996 6 : 147 153.
21. Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu CR, Liu CH et al. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 1998 128 : 262 269.
22. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001 286 : 421 426.
23. Kuller LH, Velentgas P, Barzilay J, Beauchamp NJ, O'Leary DH, Savage PJ. Diabetes mellitus: subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortality. Arterioscler Thromb Vasc Biol 2000 20 : 823 829.
24. Cerne A, Kranjec I. Atherosclerotic burden in coronary and peripheral arteries in patients with first clinical manifestation of coronary artery disease. Heart Vessels 2002 16 : 217 226.
25. Davies MJ. Acute coronary thrombosis - the role of plaque disruption and its initiation and prevention. Eur Heart J 1995 16 (Suppl. L 3 7.
26. Fallow GD, Singh J. The prevalence, type and severity of cardiovascular disease in diabetic and non-diabetic patients: a matched-paired retrospective analysis using coronary angiography as the diagnostic tool. Mol Cell Biochem 2004 261 : 263 269.
27. Figueras J, Domingo E, Hermosilla E. Long-term prognosis of clinical variables, coronary reserve and extent of coronary disease in patients with a first episode of unstable angina. Int J Cardiol 2005 98 : 27 34.
28. Shepherd J, Barter P, Carmena R, Deedwania P, Fruchart JC, Haffner S et al. Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study. Diabetes Care 2006 29 : 1220 1226.